Harrow (HROW) Gains from Sales and Divestitures (2015 - 2025)
Harrow (HROW) recorded quarterly Gains from Sales and Divestitures of $98444.0 in Q4 2025, up 2259.07% quarter-over-quarter from $4173.0 in Q3 2025, and down 69.99% on a YoY basis from $327998.0 in Q4 2024.
Harrow (HROW) Gains from Sales and Divestitures (2015 - 2025) Analysis & Trends
Harrow's Gains from Sales and Divestitures history runs 11 years deep, the most recent figure standing at $98444.0 for Q4 2025.
- In Q4 2025, Gains from Sales and Divestitures fell 69.99% year-over-year to $98444.0; the TTM figure through Dec 2025 stood at $98444.0 (down 69.99% YoY), while the FY2025 annual figure was $98444.0, down 69.99% from the prior year.
- Gains from Sales and Divestitures was $98444.0 for Q4 2025 at Harrow, up from $4173.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $1.3 million in Q4 2021 to a low of $3872.0 in Q3 2024.
- Historically, Gains from Sales and Divestitures has averaged $322474.4 across 5 years, with a median of $189965.5 in 2022.
- The sharpest annual moves came in 2021 and 2025: Gains from Sales and Divestitures jumped 6297.37% in 2021, then tumbled 98.6% in 2025.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $1.3 million in 2021, then sank by 81.4% to $237098.0 in 2022, then declined by 25.92% to $175643.0 in 2023, then soared by 86.74% to $327998.0 in 2024, then tumbled by 69.99% to $98444.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $98444.0 (Q4 2025), $4173.0 (Q3 2025), and $4173.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 98,444.00 |
| Dec 31, 2025 | 98,444.00 |
| Sep 30, 2025 | 4,173.00 |
| Sep 30, 2025 | 4,173.00 |
| Jun 30, 2025 | 4,173.00 |
| Jun 30, 2025 | 4,173.00 |
| Mar 31, 2025 | 17,410.00 |
| Mar 31, 2025 | 17,410.00 |
| Dec 31, 2024 | 327,998.00 |
| Dec 31, 2024 | 327,998.00 |
| Sep 30, 2024 | 3,872.00 |
| Sep 30, 2024 | 3,872.00 |
| Jun 30, 2024 | 298,016.00 |
| Jun 30, 2024 | 298,016.00 |
| Mar 31, 2024 | 283,389.00 |
| Mar 31, 2024 | 283,389.00 |
| Dec 31, 2023 | 175,643.00 |
| Dec 31, 2023 | 175,643.00 |
| Sep 30, 2023 | 167,253.00 |
| Sep 30, 2023 | 167,253.00 |